Alison L. Kearney

806 citations
13 papers · 475 indexed · h-index 11
Topics
Hemoglobinopathies and Related Disorders (4 papers)Metabolism, Diabetes, and Cancer (4 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)

In The Last Decade

Alison L. Kearney

13 papers receiving 469 citations

Peers

Alison L. Kearney
Comparison fields: 5 of 83
  • Molecular Biology 279
  • Physiology 88
  • Genetics 62
  • Genetics 58
  • Epidemiology 54
Replace Dena R. Yver with:
Dena R. Yver United States
Kristina M. Fetalvero United States
Rosanna Cazzolli Australia
Xu Hannah Zhang United States
Maria Teresa Rizzo United States
Michela Pellegrini Italy
Akihito Otsuki Japan
Maria Matzaris Australia
Margarete Goppelt‐Strübe Germany
Tadanori Sugimoto Japan
Alison L. Kearney relative to Dena R. Yver United States Dena R. Yver's profile →
Citations per field
00.5×7.4×
Dena R. Yver · 1×
Citations per year

Countries citing papers authored by Alison L. Kearney

Since Specialization
Citations

This map shows the geographic impact of Alison L. Kearney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison L. Kearney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison L. Kearney more than expected).

Fields of papers citing papers by Alison L. Kearney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison L. Kearney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison L. Kearney. The network helps show where Alison L. Kearney may publish in the future.

Co-authorship network of co-authors of Alison L. Kearney

This figure shows the co-authorship network connecting the top 25 collaborators of Alison L. Kearney. A scholar is included among the top collaborators of Alison L. Kearney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison L. Kearney. Alison L. Kearney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 18
2 53
3 16
4 28
5 127
6 44
7 23
8 8
9 10
10 21
11 11
12 22
13 94

About Alison L. Kearney

Alison L. Kearney is a scholar working on Genetics, Hematology and Physiology, having authored 13 papers that have together received 475 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (4 papers), Metabolism, Diabetes, and Cancer (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Genetics (62 citations), Aging (9 citations) and Molecular Biology (279 citations). Alison L. Kearney has collaborated with scholars based in Australia, United Kingdom and Canada. Frequent co-authors include David E. James, Daniel J. Fazakerley, James R. Krycer, Samantha Hocking, B Griffiths, S Povey, Sandra Gendler, Rodger W. Palmer, Dallas M. Swallow and Denise Sheer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026